Silk Road Medical announced the milestone that more than 100,000 TCAR procedures have been performed to date. “A growing number of patients come to us looking for a solution that is minimally invasive and requires less downtime so they can get back to their daily lives,” said Dr. Gregg Landis, System Chief of Vascular Surgery at Northwell Health. “It’s incredible that Silk Road was able to not only address that need by creating the TCAR procedure, but also achieve such widespread adoption in a short period of time. TCAR has transformed the way we approach treating carotid artery disease while consistently delivering positive patient outcomes.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SILK:
- Silk Road Medical Celebrates Milestone of 100,000 Transcarotid Artery Revascularization (TCAR) Procedures
- SILK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Silk Road Medical downgraded to Sell from Buy at Argus
- Silk Road Medical downgraded to Sell from Hold at Argus
- M&A News: Boston Scientific (NYSE:BSX) Will Acquire SILK For $1.2B